Open Label Two-Arm Study to Evaluate Rilzabrutinib (PRN1008) in IgG4-Related Disease Patients
An Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patients With IgG4-Related Disease An Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease ...
A randomized, double-blind controlled study of glucocorticoids combination with thalidomide in the treatment of IgG4-related diseases A randomized, double-blind controlled study of glucocorticoidscombination with thalidomide in the tr ...
Efficacy and safety of thalidomide in IgG4-related diseases
IgG4 related disease
control group:prednison combined with placebo;experimental group:prednison combined with thalidomide; control group:prednison combined with placebo;experimental group:prednison combined with thalidomide ...
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology